Sonoma Biotherapeutics
Phase 1Developing living cell therapies designed to restore balance to the immune system and ultimately cure autoimmune and inflammatory disease.
Founded
2019
Focus
Cell & Gene Therapy
About
Developing living cell therapies designed to restore balance to the immune system and ultimately cure autoimmune and inflammatory disease.
Funding History
2Total raised: $305M
Series B$265MAlly Bridge GroupJan 15, 2022
Series A$40MARCH Venture PartnersJun 15, 2020
Company Info
TypePrivate
Founded2019
LocationSeattle, United States
StagePhase 1
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile